1. Diagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases
   Xinping Zhou et al, 2016, Frontiers of Medicine CrossRef
2. Pathophysiology of thrombotic thrombocytopenic purpura
   J. Evan Sadler, 2017, Blood CrossRef
3. Lower dosages of rituximab used successfully in the treatment of anti-NMDA receptor encephalitis without tumour
   Bao-jie Wang et al, 2017, Journal of the Neurological Sciences CrossRef
4. Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission
   Manasa S. Reddy et al, 2020, Transfusion and Apheresis Science CrossRef